Program directory · Health Canada
Organs, Tissues and Blood
- Department
- Health Canada
- Program code
- BVG12 (H)
- Core responsibility
- Health Care Systems
- In Departmental Plans
- 2018-19 – 2022-23 · Appeared and later dropped
What it does
A safe and effective blood system is a cornerstone of health care delivery. The Organs, Tissues and Blood Program addresses the Health Care Systems Core Responsibility by supporting research that contributes to a safe and effective supply of blood and blood products for Canadians, and by supporting activities that contribute to Canadians' access to safe, effective donations and transplantations of organs and tissues. The entire program is delivered through funding agreements and collaborative initiatives with Canadian Blood Services (CBS), provinces and territories, and other partners. Provincial and territorial governments, which have jurisdictional authority for the delivery of organ donation, and transplantation and the transfusion of blood and blood products, also provide funding to CBS and other partners. While the organs, tissues and blood program component focuses on improving the effectiveness of the system, the blood research and development activities supports protection from health risks associated with the use of biological products through evidence-based practices to ensure the safety and supply of the Canadian blood system. An Organ Donation and Transplantation Collaborative was established in early 2018 with the purpose of supporting collaboration among and between governments, CBS and stakeholders to improve organ donation and transplantation system performance.
Source: the department's Program Inventory, via GC InfoBase.
History and lineage
First appears in GC InfoBase's actual spending by program in 2018-19. The data does not record when a program was created; it may be older than its first appearance here, which is limited by the sources (program spending starts in 2010-11, Departmental Plans in 2018-19).
| Program | Relation | Years with data | Actual spending over those years |
|---|---|---|---|
| Organs, Tissues and Blood | This program | 2018-19 – 2024-25 | $67.2M |
No earlier or later program in the same department has a similar name.
Significant changes in scope and budget
Detected from the data: renames between plans, programs it appears to replace, merge with or split into (matched by name), year-over-year changes in spending of at least 25% and $5M, or in employees of at least 20% and 25 FTEs, linked budget measures, and results indicators added or dropped.
| Year | What changed | Source |
|---|---|---|
| 2020-21 | Renamed from “Blood Systems, Organs, Tissue and Transplantation” to “Organs, Tissues and Blood”. | GC InfoBase program names by year |
| 2022-23 | Spending $21.5M, against $10.2M in 2021-22 (+111%). | Actual spending (GC InfoBase) |
| 2023-24 | Planned spending $10.1M, against $21.5M in 2022-23 (−53%). | Latest Departmental Plan |
Success criteria
The program's indicators from its department's Departmental Results Framework: the target set in each year's plan, and the result reported the following year. Source: GC InfoBase.
Historical: targets against results
Bars: result reported. Dashed line: target.
| Report year | Target | Due | Result | Status |
|---|---|---|---|---|
| 2018-19 | — | 2019 | — Target for this indicator was not specified due to Canadian Blood Services funding agreement renewal process. A target has been set for the 2019-20 reporting cycle. | No result reported |
| 2019-20 | 5 – 12 | 2020 | 11 | Met |
| 2020-21 | ≥ 5 | 2021 | 13 | Met |
| 2021-22 | ≥ 5 | 2022 | 8 | Met |
| 2022-23 | ≥ 5 | 2023 | 13 | Met |
Bars: result reported. Dashed line: target.
| Report year | Target | Due | Result | Status |
|---|---|---|---|---|
| 2019-20 | ≥ 65% | 2020 | — CIHI report: Organ replacement in Canada: Canadian Organ Replacement Register (CORR) annual statistics. Data had not been released for 2019-20 in time for reporting. | No result reported |
| 2020-21 | ≥ 65% | 2021 | 63.5% Result is below established target due to the COVID pandemic, which has decreased the number of transplants in 2020. | Not met |
| 2021-22 | ≥ 65% | 2022 | 68.8% | Met |
| 2022-23 | ≥ 65% | 2023 | 77.7% | Met |
Current: the 2026-27 plan's targets
No indicators in the 2026-27 plan.
Future goals: targets due after 2026-27
No targets with a later due date.
Spending and employees: planned against actual
Spending
Show the numbers
| Fiscal year | Planned | Actual |
|---|---|---|
| 2018-19 | $8.6M | $10.9M |
| 2019-20 | $8.6M | $13.3M |
| 2020-21 | $9.9M | $11.2M |
| 2021-22 | $10.3M | $10.2M |
| 2022-23 | $10.1M | $21.5M |
| 2023-24 | $10.1M* | — |
| 2024-25 | $10.1M* | — |
Employees (FTEs)
Show the numbers
| Fiscal year | Planned | Actual |
|---|---|---|
| 2018-19 | 0 | 1 |
| 2019-20 | 0 | 0 |
| 2020-21 | 13 | 11 |
| 2021-22 | 13 | 14 |
| 2022-23 | 13 | 14 |
| 2023-24 | 13* | — |
| 2024-25 | 13* | — |
Planned spending, plan by plan
Each row is one year's Departmental Plan and its forecast for the next three fiscal years; read a column down to see how the forecast for one year changed. The last row is what was actually spent. Click an amount for its source. Biggest changes in federal spending plans
| Plan | 2018-19 | 2019-20 | 2020-21 | 2021-22 | 2022-23 | 2023-24 | 2024-25 |
|---|---|---|---|---|---|---|---|
| 2018-19 plan | $8,580,000 | $8,580,000 | $8,580,000 | ||||
| 2019-20 plan | $8,584,021 | $8,584,021 | $8,584,021 | ||||
| 2020-21 plan | $9,880,516 | $9,880,516 | $9,880,516 | ||||
| 2021-22 plan | $10,253,160 | $10,053,160 | $10,053,160 | ||||
| 2022-23 plan | $10,055,500 | $10,055,500 | $10,055,500 | ||||
| Actual | $10,940,864 | $13,280,243 | $11,241,688 | $10,214,659 | $21,530,211 |
Actual spending is from Departmental Results Reports and the Public Accounts, as published in GC InfoBase. FTEs are full-time equivalents.
